Alwyn Capital is a venture capital firm investing in early-stage biotechnology and alternative materials companies, including plant-based proteins, cultivated meat, fermentation, recombinant technologies, alternatives to animal testing and animal-based materials. It has U.S. pre-seed investment activity and is relevant for founders building sustainability-oriented materials, life sciences and food technology companies. Portfolio companies include Emulate, Upside Foods, Geltor and Uncaged Innovations.